Ubiquitin-mediated NFκB degradation pathway

Cellular and Molecular Immunology

Volumn 12, Issue 6, 2015, Pages 653-655

  Xu, Huimin ^a   You, Mengli ^a   Shi, Haifeng ^a   Hou, Yongzhong ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

degradation; NF B; pathway; ubiquitination

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; COMMD1 PROTEIN, HUMAN; HISTONE ACETYLTRANSFERASE PCAF; P300-CBP-ASSOCIATED FACTOR; PROTEASOME; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

CD4+ T LYMPHOCYTE; ENZYME REGULATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; OPEN READING FRAME; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS INFECTION; AUTOIMMUNE DISEASE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; NEOPLASM; PATHOLOGY; PROTEIN STABILITY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AUTOIMMUNE DISEASES; GENE EXPRESSION REGULATION; HUMANS; NEOPLASMS; NF-KAPPA B; P300-CBP TRANSCRIPTION FACTORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STABILITY; PROTEOLYSIS; SIGNAL TRANSDUCTION; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 84946084205     PISSN: 16727681     EISSN: 20420226     Source Type: Journal    
DOI: 10.1038/cmi.2014.99     Document Type: Review

References (30)

1. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986; 46: 705-716.
2. Chen LF, Greene WC. Shaping the nuclear action of NFkappaB. Nat Rev Mol Cell Biol 2004; 5: 392-401.
3. Hou Y, Mortimer L, Chadee K. Entamoeba histolytica cysteine proteinase 5 binds integrin on colonic cells and stimulates NFkappaB-mediated pro-inflammatory responses. J Biol Chem 2010; 285: 35497-35504.
4. Baldwin ASJ. The transcription factorNFkBand humandisease. J Clin Invest 2001; 107: 3-6.
5. Yamamoto Y, Gaynor RB. IkappaB kinases key regulators of the NFkappaB pathway. Trends Biochem Sci 2004; 29, 72-79.
6. Solinas G, Germano G, Mantovani A, Allavena P. Tumor-Associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 2009; 86: 1065-1073.
7. Saccani S, Marazzi I, Beg AA, Natoli G. Degradation of promoterbound p65/RelA is essential for the prompt termination of the nuclear factor KB response. J Exp Med 2004; 200: 107-113.
8. Hou Y, Moreau F, Chadee K. PPARg is an E3 ligase that induces the degradation of NFkB/p65. Nat Commun 2012; 3: 1300.
9. Hou Y, Zhang Z, Xu Q, Wang H, Xu Y, Chen KP. Inhibitor of growth 4 induces NF kB/p65 ubiquitin-dependent degradation. Oncogene 2014; 33: 1997-2003.
10. Deshaies RJ, Joazeiro CA. RING domain E3 ubiquitin ligases. Annu Rev Biochem 2009; 78: 399-434.
11. Kamizono S, Hanada T, Yasukawa H, Minoguchi S, Kato R, Minoguchi M, et al. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem 2001; 276: 12530-12538.
12. Frantsve J, Schwaller J, Sternberg DW, Kutok J, Gilliland DG Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasomemediated degradation.Mol Cell Biol 2001 21 3547-3557.
13. Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, Wulf G, et al. Regulation of NFkappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 2003; 12: 1413-1426
14. Ganesh L, Burstein E, Guha-Niyogi A, Louder MK, Mascola JR, Klomp LW, et al. The gene product Murr1restricts HIV-1 replication in resting CD41 lympho-cytes. Nature 2003; 426: 853-857.
15. Marine GN, Mao X, Komarck CM, Burstein E. COMMD1 promotes the ubiquitination of NF-kB subunits through a cullin-containing ubiquitin ligase. EMBO J 2007; 26: 436-447.
16. Mao X, Gluck N, Li D, Maine GN, Li H, Zaidi IW, et al. GCN5 is a required cofactor for a ubiquitin ligase that targets NFkB/RelA. Genes Dev 2009; 23: 849-861.
17. Rodrigues L, Filipe J, Seldon MP, Fonseca L, Anrather J, Soares MP, et al. Termination of NFkB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligase. EMBO J 2009; 28: 1283-1295.
18. Tanaka T, Grusby MJ, Kaisho T. PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit. Nat Immunol 2007; 8: 584-591.
19. Fan Y, Mao R, Zhao Y, Yu Y, Sun W, Song P, et al. Tumor necrosis factor-A induces RelA degradation via ubiquitination at lysine 195 to prevent excessive nuclear factor-kB activation. J Biol Chem 2009; 284: 29290-28297.
20. Greene ME, Blumberg B, McBride OW, Yi HF, Kronquist K, Kwan K, et al. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Express 1995; 4: 281-299.
21. Girnun GD, Naseri E, Vafai SB, Qu L, Szwaya JD, Bronson R, et al. Synergy between PPARgamma ligands and platinum-based drugs in cancer. Cancer Cell 2007; 11: 395-406.
22. Zhang Z, Xu Y, Xu Q, Hou Y. PPARc against tumors by different signaling pathways. Onkologie 2013; 36: 598-601.
23. Hou Y, Gao J, Xu H, Xu Y, Zhang Z, Xu Q, et al. PPARc E3 ubiquitin ligase regulates MUC1-C oncoprotein stability. Oncogene 2013; in press
24. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004; 5: 104-112.
25. Chung SW, Kang BY, Kim SH, Pak YK, Cho D, Trinchieri G, et al. Oxidized low-density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-Activated mouse macrophages via direct interactions between peroxisome proliferator-Activated receptorgamma and nuclear factor-kappa B. J Biol Chem 2000; 275: 32681-3267.
26. Ruan H, Pownall HJ, Lodish HF. Troglitazone antagonizes tumor necrosis factor-Alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB. J Biol Chem 2003; 278: 28181-28192.
27. Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E, et al. The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 2004; 428: 328-332.
28. Coles AH, Gannon H, Cerny A, Kurt-Jones E, Jones SN. Inhibitor of growth-4 promotes IkappaB promoter activation to suppress NFkappaB signaling and innate immunity. Proc Natl Acad Sci USA 2010; 107: 11423-11428.
29. Ivanov AV, Peng H, Yurchenko V, Yap KL, Negorev DG, Schultz DC, et al. PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing. Mol Cell 2007; 28: 823-837.
30. Coscoy L, Ganem D. PHD domains and E3 ubiquitin ligases: viruses make the connection. Trends Cell Biol 2003; 13: 7-12.